DCN and neoplasm: These findings are in line with previous reports that demonstrated that either DCN or RLX gene expression in tumor tissues led to effective degradation of ECM, which ultimately led to higher level of intratumoral immune cell infiltration or distribution of co-administered therapeutics (Oh et al. 2017; Jung et al. 2020; Li et al. 2019).